<SEC-DOCUMENT>0001958244-25-004452.txt : 20251112
<SEC-HEADER>0001958244-25-004452.hdr.sgml : 20251112
<ACCEPTANCE-DATETIME>20251112080958
ACCESSION NUMBER:		0001958244-25-004452
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251112
DATE AS OF CHANGE:		20251112

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptive Biotechnologies Corp
		CENTRAL INDEX KEY:			0001478320
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				270907024
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-38957
		FILM NUMBER:		251469129

	BUSINESS ADDRESS:	
		STREET 1:		1165 EASTLAKE AVE E
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
		BUSINESS PHONE:		206-659-0067

	MAIL ADDRESS:	
		STREET 1:		1165 EASTLAKE AVE E
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptive TCR Corp
		DATE OF NAME CHANGE:	20091209

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROBINS CHAD M
		CENTRAL INDEX KEY:			0001780649
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
		STREET 2:		1551 EASTLAKE AVE E STE 200
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><ns2:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:ns2="http://www.sec.gov/edgar/ownership">
    <ns2:headerData>
        <ns2:submissionType>144</ns2:submissionType>
        <ns2:filerInfo>
            <ns2:filer>
                <ns2:filerCredentials>
                    <ns2:cik>0001780649</ns2:cik>
                    <ns2:ccc>XXXXXXXX</ns2:ccc>
                </ns2:filerCredentials>
            </ns2:filer>
            <ns2:liveTestFlag>LIVE</ns2:liveTestFlag>



        </ns2:filerInfo>
    </ns2:headerData>
    <ns2:formData>
        <ns2:issuerInfo>
            <ns2:issuerCik>0001478320</ns2:issuerCik>
            <ns2:issuerName>Adaptive Biotechnologies Corporation</ns2:issuerName>
            <ns2:secFileNumber>001-38957</ns2:secFileNumber>
            <ns2:issuerAddress>
                <com:street1>1165 Eastlake Avenue East</com:street1>
                <com:city>Seattle</com:city>
                <com:stateOrCountry>WA</com:stateOrCountry>
                <com:zipCode>98109</com:zipCode>
            </ns2:issuerAddress>
            <ns2:issuerContactPhone>1-206-659-0067</ns2:issuerContactPhone>
            <ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Chad Robins</ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <ns2:relationshipsToIssuer>
                <ns2:relationshipToIssuer>Officer</ns2:relationshipToIssuer>
            </ns2:relationshipsToIssuer>
        </ns2:issuerInfo>
        <ns2:securitiesInformation>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:brokerOrMarketmakerDetails>
                <ns2:name>Goldman Sachs &amp; Co. LLC</ns2:name>
                <ns2:address>
                    <com:street1>200 West Street</com:street1>
                    <com:city>New York</com:city>
                    <com:stateOrCountry>NY</com:stateOrCountry>
                    <com:zipCode>10282</com:zipCode>
                </ns2:address>
            </ns2:brokerOrMarketmakerDetails>
            <ns2:noOfUnitsSold>1237</ns2:noOfUnitsSold>
            <ns2:aggregateMarketValue>17973.61</ns2:aggregateMarketValue>
            <ns2:noOfUnitsOutstanding>152665188</ns2:noOfUnitsOutstanding>
            <ns2:approxSaleDate>11/11/2025</ns2:approxSaleDate>
            <ns2:securitiesExchangeName>NASD</ns2:securitiesExchangeName>
        </ns2:securitiesInformation>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:acquiredDate>03/04/2021</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Restricted Stock Units</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>The Issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>1237</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>03/04/2021</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>N</ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Chad M. Robins</ns2:name>
                <ns2:address>
                    <com:street1>1165 Eastlake Avenue East</com:street1>
                    <com:city>Seattle</com:city>
                    <com:stateOrCountry>WA</com:stateOrCountry>
                    <com:zipCode>98109</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:saleDate>11/10/2025</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>4058</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>60911.39</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Chad M. Robins</ns2:name>
                <ns2:address>
                    <com:street1>1165 Eastlake Avenue East</com:street1>
                    <com:city>Seattle</com:city>
                    <com:stateOrCountry>WA</com:stateOrCountry>
                    <com:zipCode>98109</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:saleDate>11/10/2025</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>40433</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>590010.47</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Chad M. Robins</ns2:name>
                <ns2:address>
                    <com:street1>1165 Eastlake Avenue East</com:street1>
                    <com:city>Seattle</com:city>
                    <com:stateOrCountry>WA</com:stateOrCountry>
                    <com:zipCode>98109</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common Stock</ns2:securitiesClassTitle>
            <ns2:saleDate>11/10/2025</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>41670</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>618224.45</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:remarks>The sales of shares set forth herein are made in connection with a selling plan dated 8/11/2025, that is intended to comply with Rule 10b5-1(c). Filing intended to be submitted on 11/11/2025. Unable to be submitted due to federal holiday.</ns2:remarks>
        <ns2:noticeSignature>
            <ns2:noticeDate>11/12/2025</ns2:noticeDate>
            <ns2:planAdoptionDates>
                <ns2:planAdoptionDate>08/11/2025</ns2:planAdoptionDate>
            </ns2:planAdoptionDates>
            <ns2:signature>Goldman Sachs &amp; Co. LLC on behalf of Chad Robins</ns2:signature>
        </ns2:noticeSignature>
    </ns2:formData>
</ns2:edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
